EMILY PEAK: Open Payments
NPI 1154037398 · GRANGER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$669 in 37 payments from 14 companies in 2025. Trend: 2023 $19 · 2024 $191 · 2025 $669
Food & beverage: $669
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $178 |
| Lilly USA, LLC | 10 | $137 |
| Otsuka America Pharmaceutical, Inc. | 6 | $120 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Insulet Corporation | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $20 |
Products named: REXULTI, VRAYLAR, JARDIANCE, KISUNLA, Omnipod, MOUNJARO, AIRSUPRA, ZENPEP.
Industry payments across IN — which companies pay providers there.
